{
}
UBS AG has reduced its price target for Givaudan shares from 4520 to 4380 Swiss francs while maintaining a "Neutral" rating. Analyst Charles Eden anticipates a 5% higher EBITDA for the second half of the year compared to consensus. As of 11:18 a.m., Givaudan shares fell 0.5% to CHF 4,039.00, indicating an upside potential of 8.44% based on the new target price, with a year-to-date increase of 17.9%. The company is set to release its Q4 2024 earnings on January 24, 2025.
UBS has reduced its price target for Givaudan from 4520 to 4380 Swiss francs while maintaining a "Neutral" rating. Analyst Charles Eden anticipates the company's operating result (EBITDA) for the second half of the year to exceed consensus by 5 percent, with the report due on January 24.
UBS has reduced its price target for Givaudan from 4520 to 4380 Swiss francs while maintaining a "Neutral" rating. Analyst Charles Eden anticipates the company's EBITDA for the second half of the year to exceed consensus estimates by 5 percent, with the next report due on January 24.
UBS AG maintains a "Buy" rating for Symrise shares, setting a target price of 138 euros. Analyst Charles Eden anticipates a moderate rise in production costs for flavor and fragrance manufacturers in 2025. As of 09:29 in the XETRA session, Symrise shares increased by 0.4% to EUR 102.30, indicating a potential upside of 34.90% relative to the target price.
UBS has maintained a 'Buy' rating for Symrise, setting a target price of 138 euros. Analyst Charles Eden highlighted the expected moderate increase in production costs for flavor and fragrance manufacturers in 2025, with Symrise being a global leader in this sector.
UBS AG has maintained a "Buy" rating for Symrise shares, setting a target price of €138. Analyst Charles Eden anticipates a moderate rise in production costs for flavor and fragrance manufacturers in 2025. Currently, Symrise shares are trading at €102.25, reflecting a potential upside of 34.96%.
UBS has maintained a "Buy" rating for Symrise shares, setting a target price of 138 euros, indicating a potential upside of 33.59% from the current trading price of 103.30 euros. Analyst Charles Eden noted positive margin signals and the company's goal for higher profitability. The share price has increased by 4.8% since the start of 2024, with 65,606 shares traded so far today. The Q4 2024 balance sheet is expected to be presented on March 5, 2025.
UBS has maintained a "Buy" rating for Symrise, setting a price target of 138 euros. Analyst Charles Eden noted positive margin signals during the company's Capital Markets Day, highlighting Symrise's goal of achieving structurally higher profitability.
UBS has maintained a "Buy" rating for Symrise, setting a target price of 138 euros, citing positive margin signals. The stock, trading at EUR 103.30, shows a potential upside of 33.59%. Since the start of 2024, Symrise's share price has increased by 4.8%, with Q4 2024 results expected on March 5, 2025.
UBS has maintained a 'Buy' rating for Symrise, setting a price target of 138 euros. Analyst Charles Eden highlighted positive margin signals during the Capital Markets Day, noting the company's aim for structurally higher profitability. Symrise is a leader in developing fragrances, flavors, and functional ingredients, with a diverse sales distribution across various regions and product families.
Charles Eden
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS Lowers Givaudan Price Target While Maintaining Neutral Rating
13:04 18.12.2024
ubs lowers givaudan price target to 4380 swiss francs maintains neutral rating
10:40 18.12.2024
UBS Lowers Givaudan Price Target to 4380 Swiss Francs Maintaining Neutral Rating
10:40 18.12.2024
UBS Maintains Buy Rating for Symrise with Target Price of 138 Euros
09:45 10.12.2024
UBS Maintains Buy Rating for Symrise with Target Price of 138 Euros
09:39 10.12.2024
UBS Maintains Buy Rating for Symrise with Target Price of 138 Euros
16:58 09.12.2024
ubs maintains buy rating for symrise with target price of 138 euros
15:22 21.11.2024
UBS maintains buy rating for Symrise with price target of 138 euros
14:28 21.11.2024
ubs maintains buy rating for symrise with target price of 138 euros
14:19 21.11.2024
UBS maintains buy rating for Symrise with target price of 138 euros
14:15 21.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Global Trade Developments
Stock Market Updates
Startups & Entrepreneurship
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Supply Chain Management
Cryptocurrency Trends
Private Equity Deals
Government Economic Policies
Central Bank Actions
Central Banks and Digital Currencies
Fintech Startups
CEO Changes
Workplace Trends
Blockchain Infrastructure Development
Crypto Policies and Governance
Banking Regulations
Finance Mergers & Acquisitions
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Cleanspark Inc
Citigroup Inc.
Vodafone Idea Limited
JM Financial Limited
Fuse Science, Inc.
Arla Foods A.M.B.A.
Currencies:
United States Dollar
Euro
Chinese Yuan
Indian Rupee
New Taiwan Dollar
Egyptian Pound
Hong Kong Dollar
Malaysian Ringgit
Indonesian Rupiah
Filipino Peso
West African CFA Franc
Japanese Yen
People: